Ryan Allway June 27th, 2022 News, Top News Presentation delivered by Professor Saoirse O’Sullivan at the 32nd Annual ICRS Symposium in Galway, Ireland on Sunday, June 26th SOLANA BEACH, Calif., June 27, 2022 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for... Read more
Decibel Appoints Paul Wilson as CEO
June 22, 2021
Ryan Allway June 22nd, 2021 News, Top News CALGARY, AB, June 22, 2021 /PRNewswire/ – Decibel Cannabis Company Inc. (the “Company” or “Decibel”) (TSXV: DB) (OTCQB: DBCCF), a premium cannabis producer, is pleased to announce the appointment of Paul Wilson as its Chief Executive Officer, effective Wednesday, June 23rd. Emphasizing the Company’s objective for brand... Read more
Robin Lefferts May 7th, 2021 News, Top Story Widely hailed as Cannabis 2.0, the current phase of growth in the legal cannabis market is fueled by cannabis-derived products based on oils, distillates, and isolates. These extracts contain various active ingredients, or cannabinoids, like CBD, THC, and rare cannabinoids such... Read more
Microdosing: The Next Revolution in Psychedelics
April 22, 2021
Ryan Allway April 22nd, 2021 App, Exclusive, Psychedelics, Top Story The psychedelics industry has experienced a renaissance over the past few years as researchers have opened a pandora’s box of potential. From major depression to generalized anxiety to post-traumatic stress disorder, emerging research suggests that psychedelic substances could have... Read more
Why Focus on Cannabis & Mushroom Extracts?
CBD November 25, 2020
Ryan Allway November 25th, 2020 App, Exclusive, News, Top Story Cannabis extracts are poised to become a $28.5 billion market by 2027, according to Grand View Market Research, representing a 16.6% compound annual growth rate. At the same time, the functional mushroom market is forecast to reach $34.3 billion... Read more
Ryan Allway October 23rd, 2020 German, Psychedelics Die Psychedelikaindustrie hat das Interesse von Pharmaunternehmen geweckt, die nach sichereren und effektiveren Produkten suchen, um ungedeckte medizinische Bedürfnisse im Bereich der psychischen Gesundheit zu befriedigen. Während psychedelische Moleküle vielversprechend sind, verlangen die Pharmahersteller, dass die Moleküle durch wissenschaftliche Techniken verbessert werden,... Read more
Ryan Allway May 29th, 2020 App, Exclusive, News, Top Story May 29, 2020 — Santa Monica, CA — CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announces an article discussing Israel’s... Read more
THC BioMed Reports Growing Revenue & Profitability
April 22, 2020
Ryan Allway April 22nd, 2020 App, Exclusive, News, Top Story Cannabis investors had already been shifting from “unproven potential” to “profitability” over the past several quarters prior to the global health crisis. With the COVID-19 outbreak, investors have fled previous investments to profitable companies that aren’t reliant on costly... Read more
Robin Lefferts April 3rd, 2020 App, Exclusive, News, Top News What is the ideal setting for a brand to showcase its wares to the retail consumer? It is certainly not a crowded store with hundreds of brands competing for limited shelf space and consumer attention. Every brand out there... Read more
Psychedelics: Investing in the Perfect BrainStorm
April 3, 2020
Ryan Allway April 3rd, 2020 App, Exclusive, News, Top Story Psychedelics are rapidly becoming both a mainstream treatment option and investment opportunity. With growing interest among researchers, forward-thinking companies are starting to build a presence in the space. In this article, we will take a look at the growing... Read more
